CTKB
Cytek Biosciences Inc
NASDAQ: CTKB · HEALTHCARE · MEDICAL DEVICES
$4.56
+2.70% today
Updated 2026-04-30
Market cap
$565.62M
P/E ratio
—
P/S ratio
2.81x
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$2 – $6
Volume
0.7M
Cytek Biosciences Inc (CTKB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-13.75M | $15.16M | $4.63M | $-12.23M | $5.28M | $25.38M | $-4.69M |
| Capital expenditures | $973000.00 | $1.55M | $4.36M | $9.87M | $4.83M | $3.52M | $4.08M |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $269000.00 | $611000.00 | $6.59M | $16.59M | $22.05M | $26.85M | $24.59M |
| Free cash flow | $-14.72M | $13.61M | $266000.00 | $-22.10M | $454000.00 | $21.85M | $-8.77M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $209000.00 | $1.47M | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $197.20M | $-62.63M | — | — | — |